2011
DOI: 10.1016/j.vaccine.2010.10.001
|View full text |Cite
|
Sign up to set email alerts
|

Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
51
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(52 citation statements)
references
References 63 publications
1
51
0
Order By: Relevance
“…In addition to intrinsic component, surface modification is also a routine strategy to modulate the performances of particulate adjuvants [44]. In one of the most typical examples, CD206 antibody was conjugated to the particles to guide their tracking down of DCs.…”
Section: Surface Chemical Groupmentioning
confidence: 99%
“…In addition to intrinsic component, surface modification is also a routine strategy to modulate the performances of particulate adjuvants [44]. In one of the most typical examples, CD206 antibody was conjugated to the particles to guide their tracking down of DCs.…”
Section: Surface Chemical Groupmentioning
confidence: 99%
“…Powell and colleagues investigated the in vivo immunization of mice with LbL nanoparticles with an OVA-epitope peptide incorporated within the LbL layers [134]. Single immunization, either subcutaneously or via the footpad route, elicited an antibody response and a T-cell response characterized by both effector (IFN-g) and Th2 (IL-4) responses.…”
Section: Proteinsmentioning
confidence: 99%
“…Polymeric solutions, micro-or nano-particulates can be used as effective adjuvants either alone [203] or in a complexed form with antigens [204] and/or other adjuvants [205]. Various polymers have been demonstrated to have such properties, such as polylactic acid (PLA), poly (lactide-co-glycolide) acid (PLGA) [206,207], chitosan [208][209][210][211] or modified chitosan [207], poly(-glutamic acid) (-PGA) [212,213], polypeptides [204], starch [214,215], polystyrene [35,205], polyphosphazene [216], poly (prolylene sulfide) [217], polyethylene glycol [218], alginate [219], and their copolymers [220,221].…”
Section: Polymeric Solutions or Particulatesmentioning
confidence: 99%
“…Various polymers have been demonstrated to have such properties, such as polylactic acid (PLA), poly (lactide-co-glycolide) acid (PLGA) [206,207], chitosan [208][209][210][211] or modified chitosan [207], poly(-glutamic acid) (-PGA) [212,213], polypeptides [204], starch [214,215], polystyrene [35,205], polyphosphazene [216], poly (prolylene sulfide) [217], polyethylene glycol [218], alginate [219], and their copolymers [220,221]. They enhance immunogenicity through several mechanisms, including enhancement of antigen uptake by dendritic cells (in vitro) [212], maturation of dendritic cells [212], promotion of proliferation of antigen-specific T cells [212], stimulation of both B and T lymphocytes [208], facilitation of activation of dendritic cells [222], viscosity-induced retention of antigens in the vaccination site [210] and controlled release of antigen by particles [223,224].…”
Section: Polymeric Solutions or Particulatesmentioning
confidence: 99%